Aims: Patients with severe secondary mitral regurgitation (MR) and normal ejection fraction are being excluded from clinical trials evaluating transcatheter mitral devices. We sought to e
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com